Calls for Papers: Collections in Cancer Research

Collections consist of articles on a specific topic, often overseen by a select group of expert Guest Editors. You can highlight your work and enhance your visibility within your field and community by submitting to one of our calls for papers for upcoming collections in Cancer Research.

Calls for Papers - Cancer Research

Collection

Open: 10-Oct-2023

Deadline: 10-Jul-2024

Cancer neuroscience

This Scientific Reports Collection aims to explores this connection between cancer and neuroscience and welcomes original research examining all aspects of neuro-oncology.

Read more

Dr Saurabh Agarwal: St. John’s University, USA; Dr Martin Baumgartner: University Children's Hospital Zürich, Switzerland; Prof Eliseo Eugenin: The University of Texas Medical Branch, USA

Nature Research 25 px © Springer Nature 2020


Collection

Open: 11-Oct-2023

Deadline: 31-Jul-2024

Cancer and aging

This cross-journal Collection across a range of Nature Portfolio journals invites original research exploring the role of aging in cancer and vice versa, from the bench to the bedside.

Read more

Dr Natalie R. Gassman: University of Alabama at Birmingham, USA; Dr Miguel Godinho Ferreira: Centre National de la Recherche Scientifique (CNRS) and Institute for Research on Cancer and Aging of Nice (IRCAN), France; Prof Cyrus Khandanpour: University of Luebeck and University Cancer Center Schleswig-Holstein, Germany

Nature Research 25 px © Springer Nature 2020


Collection

Open: 23-Aug-2023

Deadline: 15-May-2024

Implementation of cancer strategies in primary care: Addressing global disparities

BMC Global and Public Health is calling for submissions to our Collection on the global evidence and equity in access to cancer prevention and diagnostic strategies. BMC Global and Public Health invites the submission of Research, Comment, Review, and Opinion articles of outstanding interest covering a breadth of multi-disciplinary studies and advances in global primary care cancer strategies, ranging from observational to interventional.

Read more

Dr Tanimola Martins: University of Exeter, UK; Dr Suzanne Scott: Queen Mary University of London, UK

BMC Logo 20 px © Springer Nature 2020


Collection

Open: 21-Nov-2023

Deadline: 21-May-2024

Innate immunity in cancer

This Scientific Reports Collection aims to characterize the innate immune response in cancer and welcomes original research on the roles of all innate immune cell types in cancer.

Read more

Dr Alessandra Cambi: Radboud University Medical Centre, The Netherlands; Dr Tarik Möröy: Université de Montréal, Canada; Dr Ryohichi Sugimura: The University of Hong Kong, China

Nature Research 25 px © Springer Nature 2020

Collection

Open: 27-Nov-2023

Deadline: 27-May-2024

Cervical cancer and human papillomavirus

This collection in Scientific Reports welcomes original research on cervical cancer and HPV infection, including their epidemiology, diagnosis, treatment, and prevention.

Read more

Dr Clement Adebamowo: University of Maryland School of Medicine, USA; Prof Joakim Dillner: Karolinska Institute, Sweden; Dr Hang Yuan: Georgetown University Medical Center, USA

Nature Research 25 px © Springer Nature 2020

Collection

Open: 27-Nov-2023

Deadline: 27-May-2024

Mendelian Randomization in Cancer Diagnosis, Progression and Prognosis

This Discover Oncology Collection is dedicated to an in-depth exploration of Mendelian Randomization and its applications in cancer, pinpointing the specific genes or pathways with a causal role in cancer development. We would like to invite researchers to contribute original research and comprehensive review articles that explore the application of Mendelian Randomization in cancer-related diseases.

Read more

Prof Bin Jin: The Second Hospital of Shandong University, China; Dr Yuanbo Pan: NUS Yong Loo Lin School of Medicine, Singapore

Springer 20 px © Springer Nature 2020

Collection

Open: 27-Nov-2023

Deadline: 27-May-2024

Advances in Immunity and Immunotherapy for Blood Cancers

This Collection in Discover Oncology aims to provide a comprehensive overview of the latest breakthroughs and novel approaches in the field of immunotherapy specifically tailored for the treatment of blood cancers.

Read more

Dr Jianxun Jim Song: Texas A&M University Health Science Center, USA

Springer 20 px © Springer Nature 2020

Collection

Open: 30-Aug-2023

Deadline: 29-May-2024

Immunology and immunotherapy in solid cancers

This Collection in BMC Cancer intends to highlight innovative new research on cancer vaccines, immune checkpoint inhibition, and solid tumor resistance, inflammation, and microenvironment immunosuppression, while also delving into alternative immune treatments, as well as combinatorial approaches with standard therapies and cellular therapies. This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Read more

Dr Zachary C. Hartman: Duke University, USA; Dr Daniel Smrz: Charles University and Motol University Hospital, Czech Republic

BMC Logo 20 px © Springer Nature 2020

Collection

Open: 30-Nov-2023

Deadline: 30-May-2024

Advancing Cancer Prognosis: Integrating Multiomics and Clinical Characteristics

This Discover Oncology Collection seeks to provide a comprehensive overview of how advancements in multiomics technologies and an in-depth understanding of clinical characteristics can synergistically enhance our ability to prognosticate various cancer types accurately. Subtopics will encompass the integration of genomics, transcriptomics, proteomics, and other omics data with traditional clinical features.

Read more

Dr Dechao Feng: Sichuan University, China

Springer 20 px © Springer Nature 2020

Collection

Open: 31-Aug-2023

Deadline: 31-May-2024

Early detection and prevention of oral cancer

This new Collection in BMC Oral Health will compile dental, medical, and epidemiological research that will assist clinicians and decision-makers in identifying effective strategies to prevent oral cancer at both the patient and population levels, as well as detecting the disease, especially in "at risk" populations. This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 10: Reducing Inequalities.

Read more

Dr Márcio Diniz-Freitas: University of Santiago de Compostela, Spain; Dr Deepak Gupta: Maharishi Markandeshwar, India; Dr Shankargouda Patil: Roseman University of Health Sciences, USA; Dr Alan Roger Santos-Silva: University of Campinas, Brazil

Springer 20 px © Springer Nature 2020

Collection

Open: 28-Feb-2023

Deadline: 31-May-2024

Cancer genomics: Mutational landscape

This collection in BJC Reports aims to highlight some of the recent advances and address some of the key questions in the field of cancer genomics.

Read more

Marc Tischkowitz: University of Cambridge, UK 

Nature Research 25 px © Springer Nature 2020

Collection

Open: 28-Feb-2023

Deadline: 31-May-2024

Cancer immunotherapy: Immune checkpoint inhibitors

This BJC Reports collection aims to showcase recent developments in Cancer Immunotherapy and illustrate how some of the next challenges can be addressed.

Read more

Marc Tischkowitz: University of Cambridge, UK

Nature Research 25 px © Springer Nature 2020

Collection

Open: 16-Nov-2023

Deadline: 31-May-2024

Dietary influences on cancer biology: Separating the facts from the fluff

Amidst an abundance of dietary advice and claims, this collection in Cancer & Metabolism aims to critically examine scientific evidence surrounding the impact of diet on cancer biology. We seek contributions that elucidate the genuine connections between dietary factors, such as nutrients, bioactive compounds, and eating patterns, and their potential effects on cancer initiation, progression, and treatment outcomes.

Read more

Matthew Vander Heiden: Massachusetts Institute of Technology, USA; Michael Pollak: McGill University and Lady Davis Research Institute, Canada

BMC Logo 20 px © Springer Nature 2020

Collection

Open: 16-Nov-2023

Deadline: 31-May-2024

Role of transporters in metabolism

This Cancer & Metabolism Collection seeks to unravel the intricate connections between transporters and metabolism, and shed light on their regulatory mechanisms, impact on disease states, and potential as therapeutic targets.

Read more

Matthew Vander Heiden: Massachusetts Institute of Technology, USA; Michael Pollak: McGill University and Lady Davis Research Institute, Canada

BMC Logo 20 px © Springer Nature 2020

Collection

Open: 7-Dec-2023

Deadline: 7-Jun-2024

Tumour microenvironment

This Communications Biology Collection welcomes submissions on the interplay between tumours and their microenvironment, as well as how these interactions impact on cancer therapy.

Read more

Dr Toril Holien: Norwegian University of Science and Technology, Norway; Dr Mythreye Karthikeyan: University of Alabama at Birmingham, USA

Nature Research 25 px © Springer Nature 2020

Collection

Open: 11-Jan-2024

Deadline: 11-Jun-2024

Latest advances in brain tumor immunotherapy

This cross-journal collection in npj Precision Oncology, npj Vaccines, and Scientific Reports invites research on evolving concepts in brain tumor immunology and immunotherapy, seeking to inform next-generation therapeutic approaches for cancers in the brain.

Read more

Dr Bryan Choi: Massachusetts General Hospital and Harvard Medical School, USA; Dr Lukas Bunse: German Cancer Research Center, Heidelberg, Germany

Nature Research 25 px © Springer Nature 2020

Collection

Open: 12-Dec-2023

Deadline: 12-Jun-2024

Cancer-associated fibroblasts

This Scientific Reports Collection explores the latest research into cancer-associated fibroblasts, including the origin and function of cancer-associated fibroblasts and cancer-associated fibroblasts in the detection and treatment of cancer.

Read more

Prof Qiang Ding: University of Alabama at Birmingham, USA; Dr Carmela Ricciardelli: University of Adelaide, Australia; Dr Zhuo (Vivian) Wang: Aston University, Birmingham, UK

Nature Research 25 px © Springer Nature 2020

Collection

Open: 15-Sep-2023

Deadline: 15-Jun-2024

Tumor immune contexture in cancer progression and treatment

Genome Medicine is calling for submissions to our Collection on the tumor immune contexture in cancer progression and treatment. This Collection seeks to capture recent insights in characterizing and mapping the tumor immune contexture, dissecting response to immunotherapy, exploring anti-tumor immune responses, and uncovering parameters associated with patient outcomes, highlighting the clinical applications of these advances.

Read more

Noel De Miranda: Leiden University Medical Centre, The Netherlands

BMC Logo 20 px © Springer Nature 2020

Collection

Open: 15-Dec-2023

Deadline: 15-Jun-2024

Characterizing immune cell subsets in cancer

This Scientific Reports Collection invites original research on tumor-infiltrating immune cells, including new methods for characterizing different subsets and investigations into their different functional roles.

Read more

Tanapat Palaga: Chulalongkorn University, Thailand; Daniel R. Principe: Northwestern University, USA

Nature Research 25 px © Springer Nature 2020